New injection for easier prevention of HIV infection in the EU and worldwide
EMA has recommended granting a marketing authorisation in the European Union (EU) for Yeytuo (lenacapavir) for pre-exposure prophylaxis (PrEP) in combination with safer…, Related contentMeeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 July 2025
